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independently of asthma severity, gender,
age, and tobacco habit.Asthma treatment
prescribed for Spanish Primary Care Physi-
cians were: combined inhaled corticosteroids
and beta-agonist (62%), antil-leucotrienes
(34%), inhaled corticosteroids alone (26%),
and oral corticosteroids (5%) while 8%
received no treatment. Drugs more com-
moly prescribed for rhinitis were: antihista-
mines (45%), intranasal corticosteroids
(32%), antileucotrienes (15%), while 7%
received no treatment.
Conclusions: In Spanish Primary Care Phy-
sicians outpatient clinics, asthmatic patients
present a high prevalence of rhinitis (71%),
these patients being younger and asthma less
severe. A significant relationship was ob-
served between the severity of asthma and
rhinitis and between atopy with rhinitis and
asthma, although rhinitis treatment asso-
ciated was no related with a better lung
function.As recommended by guidelines
strategies to investigate and treat concomi-
tant rhinitis and asthma should be
considered.
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Background: Asthma and rhinitis are linked
by common inflammatory processes of
upper and lower airways, often co-exist in
the same patients and rhinitis treatment in
asthmatic patients may improve asthma
management. The aim of this study was to
investigate the prevalence and characteris-
tics of rhinitis in asthma patients attending
outpatient clinic of Spanish Pneumologist.
Methods: Asthmatic patients (n5 703) were
prospectively evaluated for rhinitis symp-
toms, severity, lung function, atopy, asthma
exacerbations, and treatment of asthma and
rhinitis, in a longitudinal study carried out
in 2005–2006 performed by 15% of Spanish
Pneumologist (n5 172), randomly distribu-
ted in Spain.
Results: Among asthmatic patients, 71%
had concomitant rhinitis. Patients with
rhinitis were generally younger(43.8 vs.
55.4 years old; Po0.001) and their asthma
was less severe (FEV1%: 85.7 vs. 79.7; Po
0.001) than those without rhinitis. A sig-
nificant correlation (r5 0.33; Po0.0001)
was foud between the severity of rhinitis
and the severity of asthma. Sensitisation to
specific allergens was strongly associated to
asthma with rhinitis (OR5 6.25;95%CI5
4.3–9.1). The prevalence of concomitant
rhinitis was higher in atopic (84%, Po
0.001) than non-atopic (51%) asthmatics.
Using multivariant analysis, patients with
treatted rhinitis had better lung function
(FEV1%: 87.3 vs. 83.4, P5 0.057)than
those without treatment, independently of
asthma severity, gender, age, and tobacco
habit. Asthma teatment prescribed by Span-
ish Pneumologist was: combined inhaled
corticosteroids and beta-agonists(72%),
anti-leucotrienes (32%), inhaled corticoster-
oids alone (20%), oral corticosteroids
(3.4%), and inmunotherapy (2.8%) while
8.1% received no treatment. Drugs more
commonly prescribed for rhinitis were:
intranasal corticosteroids (38%), antihista-
mines (30%), anti-leucotrienes (18%), and
12% received no treatment.
Conclusions: In Spanish Pneumonologist
outpatient clinics, asthmatic patients present
a high prevalence of rhinitis (71%), these
patients being younger and having an
asthma less severe. There exist a significant
relationship between the severity of asthma
and rhinitis and between atopy with rhinitis
and asthma. The treatment of rhinitis was
also associated with better pulmonary func-
tion. As recommended by guidelenes, stra-
tegies to investigate and treat concomitant
rhinitis and asthma should be considered.
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Background: Chronic Rhinosinusitis with
nasal polyps (NPs) affects 4% of the general
population in the Western world, with the
incidence in asthmatics being as high as
30%. Our aim was to characterize the
clinical pattern of patients with NPs attend-
ing our Immunoallergology Department.
Methods: The clinical files of patients with a
diagnosis of NPs attending our Immunoal-
lergology consultation in the last 12 months
were reviewed, with special attention to the
clinical history, the presence and severity of
asthma, the presence of aspirin hypersensi-
tivity, total IgE level, peripheral eosinophil
count, SPT results and finally medical and
surgical treatment. The patients were di-
vided into 3 groups depending on the
existence or absence of asthma and aspirin
hypersensitivity – Group 1 presented no
asthma or hypersensitivity to aspirin, Group
2 presented asthma without aspirin hyper-
sensitivity, and finally Group 3 presented
Widal’s triad.
Results: Fifty-five clinical files were re-
viewed (58.5% F). The results are summar-
ized in the following table:
Fifteen patients from group 3 had been
submitted to challenge tests – 11 of them
tolerated NSAIDs other than aspirin,
namely nimesulide, meloxicam and coxibs.
Conclusion: The overall incidence of asthma
in our population with nasal polyps was
84%, which is much higher than that
reported, which can be explained by the
nature of our consultation. The patients
with Widal’s Triad clearly had more severe
asthma than the other groups. It was also in
this group that the majority of SPT were
negative (80%). There was also a predomi-
nance in female patients with this syndrome.
These results appear to be in line with the
published literature.
Table 1 for abstract 1644.
Group 1 Group 2 Group 3
F/M 9 (3F/6M) 21 (13F/8M) 25 (16F/9M)
Mean Age 447 15.1 49.17 15.4 55.77 11.8
Intermittent asthma 7 (33%) 4 (16%)
Mild persistent asthma 5 (23%) 3 (12%)
Moderate persistent asthma 3 (14%) 4 (16%)
Severe persistent asthma 6 (29%) 13 (52%)
Nasal obstruction 9 (100%) 21 (100%) 25 (100%)
Hyposmia 5 (56%) 6 (29%) 11 (44%)
Nasal discharge 7 (78%) 11 (52%) 10 (40%)
Headache 4 (44%) 8 (38%) 6 (24%)
Positive SPT aeroallergens 4 (44%) 13 (62%) 5 (20%)
Nasal corticosteroids (CS) 9 (100%) 21 (100%) 25 (100%)
Oral CS 1 (11%) 4 (19%) 6 (24%)
Anti-leukotrienes 3 (33%) 15 (71%) 8 (32%)
Anti-histamines 3 (33%) 9 (43%) 9 (36%)
Nasal douche 3 (33%) 5 (24%) 4 (16%)
1 Surgery 4 (44%) 6 (29%) 9 (36%)
2 surgeries 0% 6 (29%) 2 (8%)
43 surgeries 1 (11%) 2 (10%) 2 (8%)
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